Childhood cancers: open trials in Austria

54 open trials have a site in Austria. Registry data; only the trial team decides who can take part.

NCT04877522
Asciminib Roll-over Study
Trial Treatment · Phase 4 · Novartis Pharmaceuticals
Medical University of Graz, Graz · Ordensklinikum Linz GmbH, Linz · Hanusch Krankenhaus der Wiener Gebietskrankenkasse, Vienna
Registry updated 2026-11-09
NCT03340506
Dabrafenib and/or Trametinib Rollover Study
Trial Treatment · Phase 4 · Novartis Pharmaceuticals
Medizinische Universitaet Innsbruck, Innsbruck
Registry updated 2026-11-03
NCT03435796
Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells
Trial Treatment · Phase 2/3 · Celgene
Ordensklinikum Linz GmbH, Linz · SCRI CCCIT Ges.m.b.H., Salzburg · Hanusch Krankenhaus der Wiener Gebietskrankenkasse, Vienna · Medical University of Vienna, Vienna
Registry updated 2026-11-02
NCT05376891
Met Non Small Cell Cancer Registry (MOMENT)
Research · EMD Serono Research & Development Institute, Inc.
Klinikum Klagenfurt am Woerthersee, Klagenfurt · Landeskrankenhaus Salzburg - Universitätsklinikum der PMU, Salzburg · Klinik Floridsdorf, Vienna
Registry updated 2026-10-29
NCT07899840
Establishment of a Novel Flow Cytometric Diagnostic Assay to Effectively Evaluate Immune Reconstitution After Hematopoietic Stem Cell Transplantation for Acute Lymphoblastic Leukemia
Research · Fondazione Matilde Tettamanti Menotti De Marchi Onlus
Saint Anna Kinderspital, Vienna
Registry updated 2026-10-28
NCT07476729
International Study for Treatment of Childhood Relapsed Precursor B-Cell ALL 2020 (IntReALL BCP 2020)
Trial Treatment · Phase 3 · Charite University, Berlin, Germany
Medical University of Graz, Graz · Medizinische Universitaet Innsbruck, Innsbruck · Gemeinnuetzige Salzburger Landeskliniken Betriebsgesellschaft mbH, Salzburg · St. Anna Kinderspital GmbH, Vienna
Registry updated 2026-10-26
2022-501454-11-00
International study for children and adolescents with standard risk ALK-positive anaplastic large cell lymphoma (ALCL) estimating the efficacy of Vinblastine
Trial Treatment · Phase 3 · GPOH gGmbH
Medical University of Graz, Graz · Medizinische Universitaet Innsbruck, Innsbruck · Kepler Universitaetsklinikum GmbH, Linz · Gemeinnutzige Salzburger Landeskliniken Betriebsgesellschaft mbH, Salzburg · St. Anna Kinderspital GmbH, Vienna
Registry updated 2026-10-21
NCT05476939
Biological Medicine for Diffuse Intrinsic Pontine Glioma (DIPG) Eradication 2.0
Trial Treatment · Phase 3 · Gustave Roussy, Cancer Campus, Grand Paris
Medical University of Vienna, Vienna
Registry updated 2026-10-21
NCT07211958
Study of Revumenib in Combination With Intensive Chemotherapy in Newly Diagnosed Acute Myeloid Leukemia (AML) With a NPM1 Mutation
Trial Treatment · Phase 3 · Syndax Pharmaceuticals
Medical University of Graz, Graz · Medizinische Universitaet Innsbruck, Innsbruck · Landeskrankenanstalten-Betriebsgesellschaft Kabeg, Klagenfurt Am Woerthersee · Steiermaerkische Krankenanstalten Ges.m.b.H., Leoben · Ordensklinikum Linz GmbH, Linz · Noe LGA Gesundheit Region Mitte GmbH, St. Poelten · Klinik Favoriten, Vienna
Registry updated 2026-10-21
NCT07297914
Framework for Optimizing, Refining, and Unifying Management of HSCT in Pediatric ALL
Trial Treatment · Phase 2/3 · Bambino Gesù Hospital and Research Institute
St'Anna Children Hospital, Vienna
Registry updated 2026-10-20
2022-501180-40-00
International Euro Ewing (iEuroEwing) trial for treatment optimisation in patients with Ewing sarcoma
Trial Treatment · Phase 3 · GPOH gGmbH
Medical University of Graz, Graz · Medizinische Universitaet Innsbruck, Innsbruck · Johannes Kepler University, Linz · Gemeinnutzige Salzburger Landes kliniken Betriebsgesellschaft mbH, Salzburg · St. Anna Kinderspital GmbH, Vienna
Registry updated 2026-10-19
NCT03394365
A Phase 3 Study of Tabelecleucel for Participants With Epstein-Barr Virus-Associated Post-Transplant Lymphoproliferative Disease After Failure With Rituximab or Rituximab and Chemotherapy
Trial Treatment · Phase 3 · Pierre Fabre Medicament
Medizinische Universitat Wien (Adults only), Vienna
Registry updated 2026-10-19
NCT05327894
Interfant-21 Treatment Protocol for Infants Under 1 Year With KMT2A-rearranged ALL or Mixed Phenotype Acute Leukemia
Trial Treatment · Phase 3 · Princess Maxima Center for Pediatric Oncology
Medical University of Graz, Graz · Medizinische Universitaet Innsbruck, Innsbruck · Gemeinnutzige Salzburger Landes kliniken Betriebsgesellschaft mbH, Salzburg · St. Anna Kinderspital GmbH, Vienna · St. Anna Childrens Cancer Research Institute GmbH, Vienna
Registry updated 2026-10-19
NCT01356290
Antiangiogenic Therapy for Children With Recurrent Medulloblastoma, Ependymoma, ATRT and Rare CNS Tumors
Trial Treatment · Phase 2 · Medical University of Vienna
Medical University of Graz, Graz · Medizinische Universitaet Innsbruck, Innsbruck · Johannes Kepler University Linz, Linz · Gemeinnuetzige Salzburger Landeskliniken Betriebsgesellschaft mbH, Salzburg · Medical University of Vienna, Vienna
Registry updated 2026-10-13
NCT06376162
Ziftomenib in Combination With Chemotherapy for Children With Relapsed/Refractory Acute Leukemia
Trial Treatment · Phase 1 · PedAL BCU, LLC
St. Anna Kinderspital GmbH, Vienna
Registry updated 2026-10-09
NCT07341321
SARS-CoV-2 mRNA Vaccination in Patients With Hepatocellular Carcinoma Treated With Immune Checkpoint Inhibitors
Research · Medical University of Graz
Medical University of Graz, Graz · Ordensklinikum Linz, Linz · University Hospital St. Pölten, Sankt Pölten · Krankenhaus der Barmherzigen Brüder St Veit an der Glan, Sankt Veit an der Glan · Klinikum Wels-Grieskirchen, Wels
Registry updated 2026-10-08
NCT06697301
Safety and Efficacy of EIK1001 in Combo With Pembro Versus Placebo and Pembro as First-Line Therapy in Patients With Advanced Melanoma.
Trial Treatment · Phase 2/3 · Eikon Therapeutics
Medical University of Graz, Graz
Registry updated 2026-10-06
NCT05748171
A Study to Learn More About the Study Medicine Called Inotuzumab Ozogamicin (InO) in Children (1 to <18 Years) With First Relapse ALL
Trial Treatment · Phase 2 · Pfizer
St. Anna Kinderspital GmbH, Vienna
Registry updated 2026-09-24
NCT05041309
Long-Term Follow-Up Study After Gene-Modified Cell Treatment in Kite Studies
Research · Phase 2 · Kite, A Gilead Company
Medizinische Universitaet Innsbruck, Innsbruck
Registry updated 2026-09-21
NCT07558395
Effectiveness of a Visual Telerehabilitation Program on Visual Perception in Children, Adolescents and Young Adults With Hemianopsia Consecutive to a Brain Tumour
Trial Treatment · Institut National de la Santé Et de la Recherche Médicale, France
Department of Paediatric and adolescents medicine, Medical University, Vienna
Registry updated 2026-09-16
2023-508926-91-00
SIOP RANDOMET 2017
Trial Treatment · Phase 3 · GPOH gGmbH
Medical University of Graz, Graz · Medizinische Universitaet Innsbruck, Innsbruck · Johannes Kepler University Linz, Linz · Gemeinnutzige Salzburger Landes kliniken Betriebsgesellschaft mbH, Salzburg · St. Anna Kinderspital GmbH, Vienna
Registry updated 2026-09-07
2024-516896-34-00
Phase I/II combination umbrella trial in progressive/relapsed/refractory pediatric low-grade glioma (pLGG) (EPILOGUE)
Trial Treatment · Phase 1/2 · Universitaetsklinikum Heidelberg AöR
Medical University of Vienna, Vienna
Registry updated 2026-09-07
2024-510578-25-00
SIOP-HRMB: An international prospective trial on clinically high-risk medulloblastoma (HR-MB) in patients older than 3 years.
Trial Treatment · Phase 3 · The University Of Birmingham
Medical University of Graz, Graz · Medizinische Universitaet Innsbruck, Innsbruck · Gemeinnuetzige Salzburger Landeskliniken Betriebsgesellschaft mbH, Salzburg · Medical University of Vienna, Vienna · St. Anna Kinderspital GmbH, Vienna
Registry updated 2026-09-04
NCT01949129
Allogeneic Stem Cell Transplantation for Children and Adolescents With Acute Lymphoblastic Leukaemia
Trial Treatment · Phase 2/3 · St. Anna Kinderkrebsforschung
Medical University of Graz, Graz · Medizinische Universitaet Innsbruck, Innsbruck · St. Anna Kinderspital GmbH, Vienna
Registry updated 2026-09-04
NCT02300766
Cerebellar Mutism Syndrome Study
Research · Copenhagen University Hospital, Rigshospitalet
Medical University of Vienna, Vienna
Registry updated 2026-08-12

All Childhood cancers trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error